The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Supply Chain Strategies & Solutions Article
Successful CQO initiatives must start with data that is reliable and accurate, but it takes physician leadership to make sure it is also mean
Supply Chain Strategies & Solutions Article
The ISM® Hospital Report On Business® is the first ISM® report to focus on the healthcare sector.
Webcast
This short webcast will give you a brief overview of the current ISM® Report On Business, share details surrounding the development of the new
Webcast
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the val
Webcast
In this short webcast, Chris Wiekert, senior product manager at Infor, will take you through the steps he used to lead his department in a cul
Supply Chain Strategies & Solutions Article
Real-time supply chain costs serve as an indicator of how efficiently resources are being used by different parts of the organization.